Vera Therapeutics, Inc. (VERA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US92337R1014
Vera Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Operating income | -315.47 m USD |
| EBIT | -316.56 m USD |
| Net income | -299.62 m USD |
| Diluted EPS – continuing operations | -4.66 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
More stocks
- Outokumpu Oyj (OUT1V.HE)
- SEOUL GUARANTEE INSURANCE (031210.KS)
- Progyny, Inc. (PGNY)
- Yantai Eddie Precision Mach (603638.SS)
- Thule Group AB (THULE.ST)
- NV Bekaert SA (BEKB.BR)
- Jushri Technologies Inc Class A (300762.SZ)
- Biohaven Ltd. (BHVN)
- Chervon Holdings Ltd (2285.HK)
- Kunshan Kersen Science & Tech (603626.SS)
- Chongqing Zongshen Power Machinery Co Ltd (001696.SZ)
- Sharp Corp (6753.T)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.